H-1B sponsorship profile: Mirati Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Mirati Therapeutics, Inc filed 17 Labor Condition Applications covering 17 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (17 certified of 17 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Mirati Therapeutics, Inc’s H-1B petitions range from $109,000 at the low end to $288,444 at the high end, with a petition-weighted average of $161,905. That range reflects the mix of occupations the company sponsors, led by Manager, Pharmacovigilance Submissions (3 petitions at $134,000 avg), followed by Senior Manager, Clinical Data Management and Associate Director, Biostatistics. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Mirati Therapeutics, Inc is headquartered in San Diego, CA under NAICS code 541714, and places H-1B workers across 2 states, most heavily in CA, KS. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Mirati Therapeutics, Inc ranks. By H-1B petition volume, Mirati Therapeutics, Inc is #11,465 of 119,880 employers nationally and #1,726 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.